Advertisement

Topics

Pink Sheet Podcast: Oncology Reviews, Biosimilars, and More Biosimilars

11:43 EDT 17 May 2019 | SCRIP

Our discussion of US FDA's two-drug Oncologic Drugs Advisory Committee meeting, the recent biosimilar insulin public hearing, and the new...

      

Related Stories

 

Original Article: Pink Sheet Podcast: Oncology Reviews, Biosimilars, and More Biosimilars

NEXT ARTICLE

More From BioPortfolio on "Pink Sheet Podcast: Oncology Reviews, Biosimilars, and More Biosimilars"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...